Drug Profile
MOS 118
Alternative Names: AVE-0118; MOS-118Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer Sanofi; sanofi-aventis
- Class Antiarrhythmics; Small molecules
- Mechanism of Action Potassium channel antagonists; Potassium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Sleep apnoea syndrome
- Discontinued Atrial fibrillation; Ventricular fibrillation